irsogladine has been researched along with Hypertension, Portal in 1 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, K | 1 |
| Irie, M | 1 |
| Tsuchiya, N | 1 |
| Yamauchi, E | 1 |
| Kawashima, M | 1 |
| Miyayama, T | 1 |
| Fukuda, H | 1 |
| Yamauchi, R | 1 |
| Umeda, K | 1 |
| Takata, K | 1 |
| Tanaka, T | 1 |
| Inomata, S | 1 |
| Morihara, D | 1 |
| Takeyama, Y | 1 |
| Shakado, S | 1 |
| Sakisaka, S | 1 |
| Hirai, F | 1 |
1 trial available for irsogladine and Hypertension, Portal
| Article | Year |
|---|---|
Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy.
Topics: Adult; Aged; Blotting, Western; Claudin-3; Edema; Female; Gastric Mucosa; Gene Expression; Humans; H | 2021 |